Show simple item record

dc.contributor.authorSharma, Sumeet
dc.contributor.authorFarrington, Ken
dc.contributor.authorKozarski, Robert
dc.contributor.authorChristopoulos, Christos
dc.contributor.authorNiespialowska-Steuden, Maria
dc.contributor.authorMoffat, Daniel
dc.contributor.authorGorog, Diana
dc.identifier.citationSharma , S , Farrington , K , Kozarski , R , Christopoulos , C , Niespialowska-Steuden , M , Moffat , D & Gorog , D 2012 , ' Impaired thrombolysis : a novel cardiovascular risk factor in end-stage renal disease ' , European Heart Journal , vol. 34 , no. 5 , pp. 354-363 .
dc.identifier.otherPURE: 1260628
dc.identifier.otherPURE UUID: 79017cab-8ef5-4b87-a5b6-f4dfa1aa4c75
dc.identifier.otherScopus: 84873330759
dc.description.abstractEnd-stage renal disease (ESRD) patients have an excess cardiovascular risk, above that predicted by traditional risk factor models. Prothrombotic status may contribute to this increased risk. Global thrombotic status assessment, including measurement of occlusion time (OT) and thrombolytic status, may identify vulnerable patients. Our aim was to assess overall thrombotic status in ESRD and relate this to cardiovascular risk.en
dc.relation.ispartofEuropean Heart Journal
dc.titleImpaired thrombolysis : a novel cardiovascular risk factor in end-stage renal diseaseen
dc.contributor.institutionCentre for Postgraduate Medicine
dc.contributor.institutionHealth & Human Sciences Research Institute
dc.contributor.institutionPostgraduate Medicine
dc.contributor.institutionHealth Services and Medicine
dc.contributor.institutionSchool of Life and Medical Sciences
dc.contributor.institutionCentre for Lifespan and Chronic Illness Research
dc.contributor.institutionPharmacology and Clinical Science Research
dc.description.statusPeer reviewed
dc.relation.schoolSchool of Life and Medical Sciences
rioxxterms.typeJournal Article/Review

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record